Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 4/20 | 0.50 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.50 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.50 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.50 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.50 |
| ▸ | RNASEL | Q05823 | 3/20 | 0.49 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.49 |
| ▸ | TGM2 | P21980 | 1/20 | 0.49 |
| ▸ | KRAS | P01116 | 1/20 | 0.49 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.48 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26213758 | 1.00 | P2RY1 (0.50) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26201873 | 0.97 | FUT5 (0.50) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26201802 | 0.96 | P2RY1 (0.51) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26622416 | 0.96 | RNASEL (0.54) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26201976 | 0.96 | DCPS (0.49) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26622375 | 0.94 | P2RY1 (0.53) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26201872 | 0.94 | P2RY2 (0.56) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26584183 | 0.93 | RNASEL (0.53) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26572570 | 0.93 | P2RY1 (0.52) | P2RY1P2RY2SRCP2RX1P2RX3 | |
| SCHEMBL26213547 | 0.93 | P2RY1 (0.53) | P2RY1P2RY2SRCP2RX1P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340009-A1 | COMPOUNDS FOR RNA CAPPING AND USES THEREOF | GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD. (CN) | 2023-10-26 | — | — | US | disclosed |
| WO-2023159930-A1 | COMPOUND FOR RNA CAPPING AND APPLICATION OF COMPOUND | 广州市恒诺康医药科技有限公司 | 2023-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230340009-A1 | COMPOUNDS FOR RNA CAPPING AND USES THEREOF | RNGTT, RNMT, NSUN2 | P2RY1 4192/4885P2RY2 4360/4885SRC 3673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.